The dates are set and the venue is confirmed for the Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium, April 20-22, 2017 at the Holiday Inn Golden Gateway in downtown San Francisco, centered between Nob Hill, Fisherman’s Wharf, and the Golden Gate Bridge and just steps from the historic cable cars on California Street, offering easy access the all the sites and sounds of world-famous San Francisco! A limited number of hotel rooms have been reserved at the discounted group rate of $179 per night, plus tax. Rooms in the group block are available beginning Wednesday, April 19, 2017 for three nights, also 3 days before and after the block based on availability.

We hope you will JOIN US for this biannual symposium convening the most renowned international faculty and leading experts in the field of cancer metastasis, April 20-22, 2017 in San Francisco.

The online abstract submission site will be open from February 1, 2016 through the submission deadline of September 20, 2016.

Symposium Chair, Stanley P. L. Leong, MD, FACS and the Organizing Committee will convene the most renowned international faculty and leading experts in the field of cancer metastasis, fostering genuine translational dialogue among the disciplines responsible for discovering and delivering therapies for cancer.  Cancer micro-environment and the molecular mechanisms involved in the progression of cancer cells to sentinel lymph nodes & beyond to the distant sites will be presented. The symposium will explore immune trafficking and host responses to cancer cells in detail. The topics will include:

  • Cancer Metastasis through the Lymphovascular System
  • Biomarkers for Lymphovascular Development, Growth and Neoplasia
  • Tumor Micro-environment and Tumor Progression
  • Sentinel Lymph Node Biology as a Biomarker and Gateway to Cancer Metastasis
  • Lymphogenous versus Hematogenous Cancer Spread: Independent or Connected?
  • Biomarkers for Cancer Metastasis
  • Radioimaging and Molecular Imaging of Cancer Metastasis
  • Frontiers in Immunotherapy using Checkpoint Inhibitors and Molecular Targeted Therapy

“These kind of meetings – Interactions between basic science and clinical research – should be favorably supported !! It is a melting pot for new ideas in clinical research!!”

“Excellent presentations, clear to the point. Lively discussions and good moderation. I truly enjoyed this meeting and look forward to the next one in 2 years.” Read more comments.

For more information, please contact Symposium Manager, Joan Oefner.